Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Base estimates & working
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Gene editing industry 3600 synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Application trends
2.1.3 Technology trends
2.1.4 End-user trends
2.1.5 Regional trends
Chapter 3 Gene Editing Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increased funding for genetic research in North America
3.3.1.2 Rising R&D expenditure and growth of biotechnology in Europe
3.3.1.3 Increasing demand for synthetic genes in Asia Pacific and North America
3.3.1.4 Technology advancements in gene editing in North America
3.3.2 Industry pitfalls and challenges
3.3.2.1 Stringent government regulations
3.3.2.2 Lack of public awareness in underdeveloped economies
3.4 Growth potential analysis
3.4.1 By application
3.4.2 By technology
3.4.3 By end-user
3.5 COVID-19 impact analysis
3.6 Competitive landscape, 2021
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Gene Editing Market, By Application
4.1 Key segment trends
4.2 Cell line engineering
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.3 Animal genetic engineering
4.3.1 Market size, by region, 2017-2030 (USD Million)
4.4 Plant genetic engineering
4.4.1 Market size, by region, 2017-2030 (USD Million)
4.5 Others
4.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Gene Editing Market, By Technology
5.1 Key segment trends
5.2 CRISPR/Cas9
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.3 Zinc Finger Nucleases (ZFNs)
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.4 TALENs
5.4.1 Market size, by region, 2017-2030 (USD Million)
5.5 Others
5.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 6 Gene Editing Market, By End-user
6.1 Key segment trends
6.2 Biotech and pharma companies
6.2.1 Market size, by region, 2017-2030 (USD Million)
6.3 Contract research organizations (CROs)
6.3.1 Market size, by region, 2017-2030 (USD Million)
6.4 Research institutes
6.4.1 Market size, by region, 2017-2030 (USD Million)
Chapter 7 Gene Editing Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017-2030 (USD Million)
7.2.2 Market size, by application, 2017-2030 (USD Million)
7.2.3 Market size, by technology, 2017-2030 (USD Million)
7.2.4 Market size, by end-user, 2017-2030 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by application, 2017-2030 (USD Million)
7.2.5.2 Market size, by technology, 2017-2030 (USD Million)
7.2.5.3 Market size, by end-user, 2017-2030 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by application, 2017-2030 (USD Million)
7.2.6.2 Market size, by technology, 2017-2030 (USD Million)
7.2.6.3 Market size, by end-user, 2017-2030 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017-2030 (USD Million)
7.3.2 Market size, by application, 2017-2030 (USD Million)
7.3.3 Market size, by technology, 2017-2030 (USD Million)
7.3.4 Market size, by end-user, 2017-2030 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by application, 2017-2030 (USD Million)
7.3.5.2 Market size, by technology, 2017-2030 (USD Million)
7.3.5.3 Market size, by end-user, 2017-2030 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by application, 2017-2030 (USD Million)
7.3.6.2 Market size, by technology, 2017-2030 (USD Million)
7.3.6.3 Market size, by end-user, 2017-2030 (USD Million)
7.3.7 France
7.3.7.1 Market size, by application, 2017-2030 (USD Million)
7.3.7.2 Market size, by technology, 2017-2030 (USD Million)
7.3.7.3 Market size, by end-user, 2017-2030 (USD Million)
7.3.8 Italy
7.3.8.1 Market size, by application, 2017-2030 (USD Million)
7.3.8.2 Market size, by technology, 2017-2030 (USD Million)
7.3.8.3 Market size, by end-user, 2017-2030 (USD Million)
7.3.9 Spain
7.3.9.1 Market size, by application, 2017-2030 (USD Million)
7.3.9.2 Market size, by technology, 2017-2030 (USD Million)
7.3.9.3 Market size, by end-user, 2017-2030 (USD Million)
7.3.10 Russia
7.3.10.1 Market size, by application, 2017-2030 (USD Million)
7.3.10.2 Market size, by technology, 2017-2030 (USD Million)
7.3.10.3 Market size, by end-user, 2017-2030 (USD Million)
7.3.11 Poland
7.3.11.1 Market size, by application, 2017-2030 (USD Million)
7.3.11.2 Market size, by technology, 2017-2030 (USD Million)
7.3.11.3 Market size, by end-user, 2017-2030 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017-2030 (USD Million)
7.4.2 Market size, by application, 2017-2030 (USD Million)
7.4.3 Market size, by technology, 2017-2030 (USD Million)
7.4.4 Market size, by end-user, 2017-2030 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by application, 2017-2030 (USD Million)
7.4.5.2 Market size, by technology, 2017-2030 (USD Million)
7.4.5.3 Market size, by end-user, 2017-2030 (USD Million)
7.4.6 China
7.4.6.1 Market size, by application, 2017-2030 (USD Million)
7.4.6.2 Market size, by technology, 2017-2030 (USD Million)
7.4.6.3 Market size, by end-user, 2017-2030 (USD Million)
7.4.7 India
7.4.7.1 Market size, by application, 2017-2030 (USD Million)
7.4.7.2 Market size, by technology, 2017-2030 (USD Million)
7.4.7.3 Market size, by end-user, 2017-2030 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by application, 2017-2030 (USD Million)
7.4.8.2 Market size, by technology, 2017-2030 (USD Million)
7.4.8.3 Market size, by end-user, 2017-2030 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size, by application, 2017-2030 (USD Million)
7.4.9.2 Market size, by technology, 2017-2030 (USD Million)
7.4.9.3 Market size, by end-user, 2017-2030 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017-2030 (USD Million)
7.5.2 Market size, by application, 2017-2030 (USD Million)
7.5.3 Market size, by technology, 2017-2030 (USD Million)
7.5.4 Market size, by end-user, 2017-2030 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by application, 2017-2030 (USD Million)
7.5.5.2 Market size, by technology, 2017-2030 (USD Million)
7.5.5.3 Market size, by end-user, 2017-2030 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by application, 2017-2030 (USD Million)
7.5.6.2 Market size, by technology, 2017-2030 (USD Million)
7.5.6.3 Market size, by end-user, 2017-2030 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size, by application, 2017-2030 (USD Million)
7.5.7.2 Market size, by technology, 2017-2030 (USD Million)
7.5.7.3 Market size, by end-user, 2017-2030 (USD Million)
7.6 Middle East and Africa
7.6.1 Market size, by country, 2017-2030 (USD Million)
7.6.2 Market size, by application, 2017-2030 (USD Million)
7.6.3 Market size, by technology, 2017-2030 (USD Million)
7.6.4 Market size, by end-user, 2017-2030 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by application, 2017-2030 (USD Million)
7.6.5.2 Market size, by technology, 2017-2030 (USD Million)
7.6.5.3 Market size, by end-user, 2017-2030 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by application, 2017-2030 (USD Million)
7.6.6.2 Market size, by technology, 2017-2030 (USD Million)
7.6.6.3 Market size, by end-user, 2017-2030 (USD Million)
7.6.7 UAE
7.6.7.1 Market size, by application, 2017-2030 (USD Million)
7.6.7.2 Market size, by technology, 2017-2030 (USD Million)
7.6.7.3 Market size, by end-user, 2017-2030 (USD Million)
Chapter 8 Company Profiles
8.1 Strategy dashboard, 2021
8.2 Horizon Discovery Ltd.
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Sangamo Therapeutics, Inc.
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 GeneScript
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Integrated DNA Technologies, Inc.
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Precision Biosciences
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Beam Therapeutics
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Thermo Fisher Scientific
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Intellia Therapeutics, Inc.
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 CRISPR Therapeutics
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Caribou Biosciences, Inc.
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
